SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-038260
Filing Date
2013-07-30
Accepted
2013-07-30 11:58:56
Documents
1
Period of Report
2013-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14377
  Complete submission text file 0001209191-13-038260.txt   17014
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Reporting) CIK: 0000816284 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 13994761
SIC: 2834 Pharmaceutical Preparations

Mailing Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-272-5275
AGIOS PHARMACEUTICALS INC (Issuer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 908-673-9000
Celgene European Investment Co LLC (Reporting) CIK: 0001577650 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 13994762

Mailing Address 86 MORRIS AVENUE SUMMIT X1 07901
Business Address 86 MORRIS AVENUE SUMMIT X1 07901 908-673-9000
Celgene Alpine Investment Co., LLC (Reporting) CIK: 0001581774 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 13994760